Cancer Diagnostics Market Analysis by Type (Genetic Tests, Laboratory Tests, Imaging), by Application (Blood Cancer, Breast Cancer, Kidney Cancer, Lung Cancer, Skin Cancer), and by Region - Forecast to 2029

Request Sample Page

The global cancer diagnostics market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Increase in global cases of cancer is a key driver for the growth of the global cancer diagnostics market. Additionally, rise in the number of private diagnostic centres and accessibility of repayment in the cancer diagnostics market are some of the other drivers propelling the market growth. Nevertheless, capital intensive market and low cost-benefit percentage for biomarkers and rising cost of diagnostic imaging systems are expected to restrain the global market growth.

Global Cancer Diagnostics Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is segmented into genetic tests, laboratory tests, endoscopy, imaging, biopsy, and other. In 2021, the imaging segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the increase in application of various imaging modalities such as CT scan and MRI along with genetic and laboratory test for diagnosis of the type of cancer, its location and severity of the cancer worldwide. Laboratory and genetic tests segment projected to grow at a profitable CAGR during the forecast period. This is attributed to both these tests being performed in together to help in confirming the presence or absence of tumor cells along with genetic mutations.

By Application

Based on application, the market is segmented into blood cancer, breast cancer, colorectal cancer, prostate cancer, cervical cancer, kidney cancer, lung cancer, skin cancer, pancreatic cancer, ovarian cancer, and others. In 2021, the breast cancer segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to an increase in the awareness of the people, along with various campaigns indorsing routine mammography, is resulting in rising demand for imaging solutions in breast cancer screening worldwide. Kidney and liver cancer segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the growth in the consumption of tobacco and alcohol which results in increased occurrence of tumor in the liver and kidney.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major biotechnology and medical device manufacturers in the region, increase in the share of healthcare expenditure in the per capita income, increase in the initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the availability of huge patient pool, growing government and corporate investment in healthcare sector, well-defined regulatory framework that provides benefit for frequent new product launches, and growing medical tourism in countries such as China and India are the major factors in this region.

Competitor Insights

Some of the key players in the cancer diagnostics market are GE Healthcare (U.S.); Abbott Laboratories (U.S.); Hologic Inc. (U.S.); Agilent Technologies Inc.(U.S.); F. Hoffmann-La Roche AG (Switzerland); FUJIFILM Corporation (Japan); Danaher Corporation (U.S.); DiaSorin S.P.A. (Italy); Myriad Genetics Inc. (U.S.); Siemens Healthineers AG (Germany); bioMérieux SA (France); Bio-Rad Laboratories (U.S.); and Cancer Diagnostics Inc. (U.S.). The leading players operating in the cancer diagnostics industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The cancer diagnostics market report is categorized into the following segments and subsegments:

Cancer Diagnostics Market, By Type (Revenue, USD Billion, 2021 – 2029)

  • Genetic Tests
  • Laboratory Tests
  • Endoscopy
  • Imaging
  • Biopsy
  • Other

Cancer Diagnostics Market, By Application (Revenue, USD Billion, 2021 – 2029)

  • Blood Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Lung Cancer
  • Skin Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

Cancer Diagnostics Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Cancer Diagnostics Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Cancer Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Cancer Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Cancer Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Type
    1. Genetic Tests
      1. Genetic Tests Market Forecast, 2021-2029 (USD Million)
    2. Laboratory Tests
      1. Laboratory Tests Market Forecast, 2021-2029 (USD Million)
    3. Endoscopy
      1. Endoscopy Market Forecast, 2021-2029 (USD Million)
    4. Imaging
      1. Imaging Market Forecast, 2021-2029 (USD Million)
    5. Biopsy
      1. Biopsy Market Forecast, 2021-2029 (USD Million)
    6. Other
      1. Other Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Blood Cancer
      1. Blood Cancer Market Forecast, 2021-2029 (USD Million)
    2. Breast Cancer
      1. Breast Cancer Market Forecast, 2021-2029 (USD Million)
    3. Colorectal Cancer
      1. Colorectal Cancer Market Forecast, 2021-2029 (USD Million)
    4. Prostate Cancer
      1. Prostate Cancer Market Forecast, 2021-2029 (USD Million)
    5. Cervical Cancer
      1. Cervical Cancer Market Forecast, 2021-2029 (USD Million)
    6. Kidney Cancer
      1. Kidney Cancer Market Forecast, 2021-2029 (USD Million)
    7. Lung Cancer
      1. Lung Cancer Market Forecast, 2021-2029 (USD Million)
    8. Skin Cancer
      1. Skin Cancer Market Forecast, 2021-2029 (USD Million)
    9. Pancreatic Cancer
      1. Pancreatic Cancer Market Forecast, 2021-2029 (USD Million)
    10. Ovarian Cancer
      1. Ovarian Cancer Market Forecast, 2021-2029 (USD Million)
    11. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Cancer Diagnostics Market
    1. North America Cancer Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. S. Cancer Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Canada Cancer Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Europe Cancer Diagnostics Market
    1. Europe Cancer Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Germany Cancer Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. UK Cancer Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. France Cancer Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Spain Cancer Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Italy Cancer Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Europe Cancer Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Asia Pacific Cancer Diagnostics Market
    1. Asia Pacific Cancer Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Japan Cancer Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. China Cancer Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. India Cancer Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. South Korea Cancer Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Cancer Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Cancer Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Latin America Cancer Diagnostics Market
    1. Latin America Cancer Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Brazil Cancer Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Mexico Cancer Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Argentina Cancer Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Rest of Latin America Cancer Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. MEA Cancer Diagnostics Market
    1. MEA Cancer Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. GCC Cancer Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. South Africa Cancer Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Rest of MEA Cancer Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. GE Healthcare (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    2. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    3. Hologic Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    4. Agilent Technologies Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    5. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    6. FUJIFILM Corporation (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    7. Siemens Healthineers AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    8. bioMérieux SA (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    9. Bio-Rad Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    10. Cancer Diagnostics Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports